Elon Musk has reported the successful implantation of a Neuralink brain device in the inaugural human patient, noting the individual’s positive recovery one day post-surgery. This development marks a crucial step for Neuralink, a company dedicated to advancing brain-computer interfaces (BCI). Neuralink initiated its first clinical trial last fall, receiving FDA approval and targeting individuals with quadriplegia due to spinal cord injury or amyotrophic lateral sclerosis (ALS) for participation. The primary objective of Neuralink’s BCI is to empower individuals to control computer cursors or keyboards solely through their thoughts, addressing the needs of those with spinal cord injuries or ALS.
Read: ROG is shaking up the gaming laptop industry with the new Zephyrus G14 and G16
During the announcement, Musk did not divulge additional procedural specifics or the trial’s current status. However, he expressed optimism by stating that the “initial results show promising neuron spike detection.” The successful integration of Neuralink’s device into a human patient stands as a significant milestone for the company. Elon Musk has previously asserted that Neuralink’s technology could eventually offer individuals the ability to immerse themselves in alternate realities. Simultaneously, Neuralink faces a federal investigation concerning allegations of violating animal welfare laws, underscoring the ethical considerations surrounding its research and development efforts.